GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luye Pharma Group Ltd (STU:LUP) » Definitions » Price-to-Operating-Cash-Flow

Luye Pharma Group (STU:LUP) Price-to-Operating-Cash-Flow : 5.78 (As of Jun. 21, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Luye Pharma Group Price-to-Operating-Cash-Flow?

As of today (2024-06-21), Luye Pharma Group's share price is €0.318. Luye Pharma Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.06. Hence, Luye Pharma Group's Price-to-Operating-Cash-Flow Ratio for today is 5.78.

The historical rank and industry rank for Luye Pharma Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:LUP' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.27   Med: 17.89   Max: 58.15
Current: 6.1

During the past 13 years, Luye Pharma Group's highest Price-to-Operating-Cash-Flow Ratio was 58.15. The lowest was 5.27. And the median was 17.89.

STU:LUP's Price-to-Operating-Cash-Flow is ranked better than
87.35% of 680 companies
in the Drug Manufacturers industry
Industry Median: 16.105 vs STU:LUP: 6.10

Luye Pharma Group's Cash Flow from Operations per share for the six months ended in Dec. 2023 was €0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.06.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Luye Pharma Group was -11.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 6.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -1.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -1.30% per year.

During the past 13 years, Luye Pharma Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 50.60% per year. The lowest was -44.00% per year. And the median was 19.20% per year.


Luye Pharma Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Luye Pharma Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luye Pharma Group Price-to-Operating-Cash-Flow Chart

Luye Pharma Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.89 9.35 54.77 6.89 7.97

Luye Pharma Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.77 - 6.89 - 7.97

Competitive Comparison of Luye Pharma Group's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Luye Pharma Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luye Pharma Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Luye Pharma Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Luye Pharma Group's Price-to-Operating-Cash-Flow falls into.



Luye Pharma Group Price-to-Operating-Cash-Flow Calculation

Luye Pharma Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.318/0.055
=5.78

Luye Pharma Group's Share Price of today is €0.318.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Luye Pharma Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Luye Pharma Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Luye Pharma Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Luye Pharma Group (STU:LUP) Business Description

Traded in Other Exchanges
Address
No. 15 Chuang Ye Road, High-tech Industrial Development Zone, Shandong, Yantai, CHN, 264003
Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on developing, producing, and selling pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company's highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for global use in Asia, Europe, and the United States.

Luye Pharma Group (STU:LUP) Headlines

No Headlines